Abstract:OBJECTIVE:To screen and identify peptides that binds specifically to gastric cancers cells with high metastasis to peritoneum so as to find appropriate vectors for targeting therapy for cancer.METHODS:Human gastric cancer cells of the line GC9811 and those with high metastasis to peritoneum of the line GC9811-P were co-incubated with the 12-mer bacteriophage random peptide library. After 3 round of repeated screening, phage clones were collected. Forty internalized phage single-stranded DNA that specifically binding to the GC98112-P cells were sequenced. GC9811 and GC9811-P cells were co-inoculated with 5 peptides with the N end marked with fluorescein isothiocyanate (FITC) and 1 un-related peptide not binding to GC9811 and GC9811-P cells. Fluorescence microscopy, ELISA, and flow cytometry were used to detect the binding activity. BALB/cnu/nu mice were inoculated intraperitoneally with GC9811 and GC9811-P cells and then randomly divided into. 2 equal groups: experimental group, inoculated with the peptide PIII-FITC and control group (inoculated with un-related peptide PC-FITC. Forty-eight hours later the mice were killed and the peritoneum and tumor masses in different organs were collected and under fluorescence microscopy.RESULTS:DNA sequencing showed that 45% (18/45) of the isolated phages displayed repeated sequence SMSIASPYIALE, and SMSI was defined as a conservative motif. Obvious fluorescence was seen in the GC9811-P cells co-incubated with PIII-FITC and weak fluorescence was seen in the GC9811 cells co-incubated with PIII-FITC. Un-marked un-related peptide PC and PIII-FITC did not influenced the fluorescence staining of the GC9811-P cells, however, no fluorescence could be seen in the GC9811-P cells co-incubated with un-marked PIII and PIII-FITC. The fluorescence positive cell rate was 5.9% in the GC9811 cells co-incubated with PIII-FITC, and was 90.2% in the GC9811-P cells co-incubated with PIII-FITC. The fluorescence positive cell rates of the GC9811 cells and GC9811-P cells co-incubated with PC-FITC were 10.1% and 9.9% respectively 10.1% and 9.9% respectively. The fluorescence strength of the GC9811-P cells co-incubated with PIII-FITC was significantly greater than that of the GC9811-P cells co-incubated with PC-FTIC at any time-point and dose (all P < 0.01), and increased along with the increase of co-incubation time and dose of PIII-FITC. The peritoneal tumor tissues caused by the GC9811-P cells of the mice showed strong fluorescence and those caused by GC9811 cells only showed very weak fluorescence. Weak fluorescence could be seen in the tumor masses in the lymph nodes, liver, and muscle of the mice inoculated with GC9811-P cells and was not seen in the tissues of the mice inoculated with GC9811 cells.CONCLUSION:The sequence SMSIASPYIALE that specifically binds to human gastric cancer cells with high metastasis has been screened that has the potential to be used as a marker and targeting vector in diagnosis and treatment of gastric cancer.

Inhibiting Effects of a Cyclic Peptide CNGRC on Proliferation and Migration of Tumor Cells In Vitro

Effect of laminin tyrosine-isoleucine-glycine-serine-arginine peptide on the growth of human prostate cancer (PC-3) cells in vitro.

Antitumor Activity of Antimicrobial Peptides Containing CisoDGRC in CD13 Negative Breast Cancer Cells

The Inhibition Effects of c (RGD) 2 Peptides on Proliferation in B16 Melanoma Cells and the Its Imaging and Biodistribution Study in Tumor-bearing Mice

The CNGRCLLII(KLAKLAK)2 Peptide Shows Cytotoxicity Against HUVECs by Inducing Apoptosis: an in Vitro and in Vivo Study

Inhibitory Effects of Novel Integrin-Targeting Peptides on Angiogenesis Activity in HUVEC Cells in Vitro.

Efficacy of Inverso Isomer of CendR Peptide on Tumor Tissue Penetration

Modification Of Cyclic Ngr Tumor Neovasculature-Homing Motif Sequence To Human Plasminogen Kringle 5 Improves Inhibition Of Tumor Growth

A Novel Peptide (GX1) Homing to Gastric Cancer Vasculature Inhibits Angiogenesis and Cooperates with TNF Alpha in Anti-Tumor Therapy

Specific Targeting of the Vasculature of Gastric Cancer by a New Tumor-Homing Peptide CGNSNPKSC.

A Cyclic Peptide Epitope of an Under-Explored VEGF-B Loop 1 Demonstrated In Vivo Anti-Angiogenic and Anti-Tumor Activities

An antimicrobial peptide containing NGR motif has potent antitumor activity against CD13+ and CD13− tumor cells

Cell-penetrating peptides in cargo delivery : In vitro studies on uptake and in vivo studies on tumor targeting

Targeting aminopeptidase N (APN/CD13) with cyclic-imide peptidomimetics derivative CIP-13F inhibits the growth of human ovarian carcinoma cells.

Selection of a Specific Binding Peptide Targeting to Blood Vessel of Human Gastric Cancer in Vivo and Modeling of Its Three Dimensional Structure

Screening and Identification of Vascular-Endothelial-cell-specific Binding Peptide in Gastric Cancer

Inhibitory Effects of Synthetic Β Peptide on Invasion and Metastasis of Liver Cancer

The Tumour Neovasculature-Homing Dimeric Peptide GX1 Demonstrates Antiangiogenic Activity in the Retinal Neovasculature

Tumor penetrability and anti-angiogenesis using iRGD-mediated delivery of doxorubicin-polymer conjugates.

Characterization of a specific phage-displayed Peptide binding to vasculature of human gastric cancer.

[Preliminary Screening and Identification of a Peptide That Binds Specifically to Gastric Cancers Cells with High Metastasis to Peritoneum].